Showing results (441-450 of 539) with videos related to
Sort By:
Pageof 54
Joint Bone Spine|February 22, 2021
Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS)Camille Villon, Laure Orgeolet, Anne-Marie Roguedas, et al.Annals of the Rheumatic Diseases|December 25, 2025
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's diseaseBaptiste Chevet, Valérie Devauchelle-Pensec, Elena Pontarini, et al.Rheumatology (Oxford, England)|March 2, 2024
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositisQuentin Astouati, Thomas Machet, Camille Houssais, et al.Rheumatology (Oxford, England)|May 10, 2015
Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacyDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.Annals of the Rheumatic Diseases|May 16, 2012
Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas surveyBenjamin Terrier, Fabrice Carrat, Evguenia Krastinova, et al.Drugs & Aging|February 23, 2021
Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren's SyndromeSoledad Retamozo, Chiara Baldini, Hendrika Bootsma, et al.European Journal of Cancer (Oxford, England : 1990)|August 28, 2021
Immune checkpoint inhibitor-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuationNoémie Chanson, Manuel Ramos-Casals, Xerxes Pundole, et al.Nature|March 28, 2014
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanomaChong Sun, Liqin Wang, Sidong Huang, et al.Journal of Internal Medicine|November 28, 2023
Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohortKevin Chevalier, Benjamin Thoreau, Marc Michel, et al.Plos One|September 15, 2015
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, et al.Pageof 54